Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001
-
Shares outstanding
-
53,041,500
-
Total 13F shares
-
27,412,381
-
Share change
-
-1,296,310
-
Total reported value
-
$173,379,386
-
Put/Call ratio
-
359%
-
Price per share
-
$6.32
-
Number of holders
-
107
-
Value change
-
-$6,527,556
-
Number of buys
-
52
-
Number of sells
-
41
Institutional Holders of Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) as of Q2 2023
As of 30 Jun 2023 Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) had 107 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 27,412,381 shares of stock of the company.
Largest 10 holders included CAS Investment Partners, LLC, BlackRock Inc., 683 Capital Management, LLC, VANGUARD GROUP INC, BAILLIE GIFFORD & CO, KPS Global Asset Management UK Ltd, MARSHALL WACE, LLP, D. E. Shaw & Co., Inc., WORLDLY PARTNERS MANAGEMENT, LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This table shows 107 institutional shareholders of the security as of 30 Jun 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.